Oncology

The American Journal of Managed Care presents exclusive videos from the 2013 Patient-Centered Oncology Care: Real-World Perspectives conference.

Investigators strengthened the results of a 2012 trial with a long-term follow-up of an important phase III trial evaluating a bortezomib-based regimen versus a vincristine-based regimen.

Patients who received lower levels of opioid painkillers due to use of neuraxial analgesia along with general anesthesia had lower levels of systematic progression and overall death than those who received general anesthesia alone.

The latest lung cancer screening recommendations suggest that heavy smokers be screened for the disease annually once they reach 55 years of age.

The vasopressin-2 receptor antagonist tolvaptan was effective at treating hyponatremia in 10 patients with small cell lung cancer, according to a prospective case series report.

November, or Movember, has become a month in which normally clean-shaven men grow mustaches to help raise awareness about men's health and the need to get screened for conditions such as prostate and testicular cancer.

New research suggests that yoga may help cancer survivors sleep more and sleep better after treatment.

Risk of death from prostate cancer was reduced for patients who started taking statins after being diagnosed with the disease and was reduced even more for those who started taking statins before being diagnosed.

Those concerned about different types of cancer should band together to support research into prevention, detection, and cure-and to counter the exorbitant expense of treatment.

A study including 10 million patients covered by 11 health plans suggested that insurance claims could be used to estimate the number of early-stage breast cancer cases as well as the demand for anti-HER2 drugs.

Gilotrif (afatinib) is a first-line oral treatment for certain non-small cell lung cancers.

After successful treatment for early-state prostate cancer, Rick Lyke decided to raise awareness of the disease among men by appealing to their interest in beer.

Since prostate cancer frequently progresses very slowly, active surveillance is a frequent option, but where necessary, surgery, radiation therapy, hormone therapy, and chemotherapy can be used.

According to the results of a large cohort study, men with high blood concentrations of omega-3 fatty acids may be at an increased risk for developing prostate cancer.

Keeping up with advances in oncology is a welcome challenge.

Survival rates are generally quite high for the second-most-common cancer among men in the United States.

Oral antineoplastics have advantages, but patient adherence is a concern.

Incremental gains in survival and new targeted agents in the pipeline offer promise.

As pharmacogenomics continues to progress, specialty pharmacists may dominate treatment for certain diseases.